DSRU Scientific Publications

Use our keyword search facility to match our publications with your area of interest.

253 publications found, showing 101 to 120

Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database
Clark DW, Layton D, Wilton LV, Pearce GL, Shakir SA,
Drug Saf. January 2001
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring
Layton D, Pearce GL, Shakir SA,
Drug Saf. January 2001
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies
Martin RM, Shakir S,
Drug Saf. January 2001
Incompleteness of lamotrigine data
Acharya NV, Wilton LV, Shakir SA,
Drug Saf. January 2001
Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting
Biswas P, Wilton LV, Shakir SA,
Drug Saf. January 2001
Incompleteness of lamotrigine data (multiple letters)
Acharya NV, Wilton LV, Shakir SA, Messenheimer JA, Risner ME, Giorgi L,
Drug Saf. January 2001
Pharmacosurveillance and safety of the leukotriene receptor antagonist (LTRA), montelukast
Biswas P, Wilton L, Pearce G, Freemantle S, Shakir S, Mann RD,
Clin & Exp Allergy Reviews. January 2001
Principles of Pharmacovigilance
Biswas P, Shakir SAW,
Pharm Physician. January 2001
Pharmacovigilance and the Community Pharmacist
Layton D,
Prescriber. January 2001
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies
Martin RM, Dunn NR, Freemantle S, Shakir S,
Br J Clin Pharmacol. October 2000
Costs of seeking ethics approval before and after the introduction of multicentre research ethics committees
Dunn NR, Arscott A, Mann RD,
J R Soc Med. October 2000
The pharmacovigilance of tamsulosin: Event data on 12,484 patients
Mann RD, Biswas P, Freemantle S, Pearce G, Wilton L,
BJU International. June 2000
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding
Dunn NR, Pearce GL, Shakir SA,
BMJ. May 2000
Association between SSRIs and upper gastrointestinal bleeding (multiple letters)
Williams D, Kelly A, Feely J, Dunn NR, Pearce GI, Shakir SAW, Dickinson T, Malhi S, Painter S, Pyott J, Sawhney A, De Abajo F, Montero D, Rodriguez LAG,
BMJ. May 2000
Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales
Dunn NR, Arscott A, Thorogood M, Faragher B, De Caestecker L, MacDonald TM, McCollum C, Thomas S, Mann RD,
J Epidemiol Community Health. April 2000
Adverse effects associated with the use of donepezil in general practice in England
Dunn NR, Pearce GL, Shakir SA,
J Psychopharmacol. January 2000
Sedation with 'non-sedating' antihistamines: four prescription-event monitoring studies in general practice
Mann RD, Pearce GL, Dunn N, Shakir S,
BMJ. January 2000
QT lengthening and life-threatening arrhythmias associated with fexofenadine
Craig-McFeely PM, Freemantle SL, Pearce GL, Shakir SA,
Br J Gen Pract. January 2000
Drug safety research unit and pharmacoepidemiology
Shakir S, Wilton L,
Int J Pharm Med. January 2000
The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: Cohort study
Martin RM, Biswas P, Mann RD,
Br J Clin Pharmacol. January 2000

Drug Safety Research Unit

DSRU Scientific Publications